AndreaBozzo/ceres-open-data-index huggingface dataset:
Compound 528054: L-Leucine, N-(tert-butyldimethylsilyl)-, tert-butyldimethylsilyl ester

Chemical compound data from PubChem database. IUPAC Name: [tert-butyl(dimethyl)silyl] 2-[[tert-butyl(dimethyl)silyl]amino]-4-methylpentanoate. Molecular Formula: C18H41NO2Si2. Molecular Weight: 359.7. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Albuquerque, NM

This report presents combined 2005 to 2010 National Survey on Drug Use and Health (NSDUH) results for those aged 12 or older in the Albuquerque, New Mexico metro area. The report includes estimates of substance use disorder, major depressive episode, illicit drug use, marijuana use, cigarette use, binge alcohol use, and the nonmedical use of prescription-type pain relievers. Results are provided for Albuquerque, New Mexico, and the U.S. overall.
Vermont (VT)

This report presents Vermont\'s estimates for 25 measures of substance use and mental health based on the combined 2009 and 2010 National Surveys on Drug Use and Health (NSDUHs). Topics covered include past month substance use (e.g., illicit drugs, marijuana, cocaine, pain relievers, alcohol, tobacco), substance dependence, abuse, and treatment need, past year serious mental illness (SMI), any mental illness (AMI), suicidal thoughts, and major depressive episode (MDE). Resuts are provided for Vermont for five age groups: 12 to 17, 18 to 25, 26 or older, 18 or older and all persons 12 or older.
Emergency Temporary Shelters - Grievances Resolved

Under <a href="https://chicityclerkelms.chicago.gov/Matter/?matterId=6DEAA6D8-D0E6-EE11-904C-001DD806E058" target="_blank">SO2024-0008386</a>, passed by City Council on 4/17/2024, the Department of Family and Support Services publishes data on the City-operated and City-funded emergency new arrivals shelters. This dataset shows resolved grievances filed by migrants staying at the shelters, grouped by type and the two-week period in which the grievance was resolved. Grievances not yet resolved are not included.
Wisconsin 2016 Potential Areas for Addressing Service Gaps for Opioid Treatment

The purpose of the medication-assisted treatment (MAT) facility maps is to identify areas on a state-by-state basis that may be potentially underserved by existing treatment facilities. The maps are created with a methodology that seeks to include the highest potential need areas from individual counties so that county-level stakeholders are also informed. The maps are meant to be used as a tool for policy makers to determine potentially underserved areas—not as a definitive representation of these areas.
Compound 525272: N'-(3-methyl-phenyl)-N,N-dimethyl-acetamidine

Chemical compound data from PubChem database. IUPAC Name: N,N-dimethyl-N'-(3-methylphenyl)ethanimidamide. Molecular Formula: C11H16N2. Molecular Weight: 176.26. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Patent AT-E399622-T1: [Translated] DEVICE FOR FINISHING METAL EDGES ATTACHED TO PANELS

Device for finishing metal edges (B) fitted to wood panels (P), comprising a surface finishing tool able to treat at least one milled zone of the metal edge. The tool consists of an idle roller (6) with an external incision surface able to rotate in contact with the zone of the edge so as to impress on it a mark when the panel is displaced with a relative movement with respect to the device in a feeding direction.
Patent AT-E400688-T1: [Translated] WATER DISCHARGE DEVICE FOR A WASHING MACHINE

The water removal device has a line (4) carrying water from a pump (2) to an outlet (3) and containing at least one container, a connecting pipe and an elbow union pipe. The line contains a body or a one-piece part formed by the container and at least one of the other two elements. The assembly formed by the container and connecting pipe is connected to the elbow union pipe directly or via a connecting part.
Patent AT-E40141-T1: [Translated] PROCESS FOR THE PREPARATION OF HGRF (SOMATOCRININ) IN LIQUID PHASE AND PEPTIDE INTERMEDIATE COMPOUNDS.

A process for the synthesis, in liquid phase and by fragments, of hGRF 1-44 and hGRF 1-40. This process consists in coupling, one after the other and in the order of the sequence of the GRF, (1) on the one hand, the following fragments: -H-Ala-Arg-Ala-Arg-Leu-NH2 called Fragment A hGRF (40-44) or -   alaninamide (40) -H-Gln-Glu-Arg-Gly-OH called Fragment B'1 hGRF (36-39) -H-Glu-Ser-Asn-OH called Fragment B'2 hGRF (33-35) -H-Ser-Arg-Gln-Gln-Gly-OH called Fragment C hGRF (28-32) -H-Leu-Gln-Asp-Ile-Met-OH called Fragment D' hGRF (23-27) -H-Arg-Lys-Leu-OH called Fragment E'1 hGRF (20-22) -  to obtain the peptide K1 [(hGRF (20-44)] on the corresponding peptide having the sequence (20-40) and (2) on the other hand, the following fragments: -H-Gln-Leu-Ser-Ala called Fragment F1 hGRF (16-19) -H-Tyr-Arg-Lys-Val-Leu-Gly OH called Fragment G1 hGRF (10-15) -H-Ile-Phe-Thr-Asn-Ser-OH called Fragment H1 hGRF (5-9) -  to obtain the peptide J [hGRF (5-19)] and thereafter to couple together the peptides J and K1 in order to form the peptide having the sequence hGRF (5-44) or hGRF (5-40) and finally to couple the resulting peptide with the peptide H-Tyr-Ala-Asp-Ala-OH, called fragment I hGRF (1-4).
2014 CMHS Uniform Reporting System (URS) Table for Florida

2014 Center for Mental Health Services (CMHS) Uniform Reporting System (URS) Output Tables for Florida. The URS state reporting system is collected annually to support the Community Mental Health Services Block Grant program. State Mental Health Authorities report on National Outcome Measures (NOMS), evidence based practices, and utilization measures providing an overview of state mental health delivery systems.
A High-throughput, Turbulent-mixing, Condensation Aerosol Concentrator for Direct Aerosol Collection as a Liquid Suspension

Trace measurement of aerosol chemical composition in workplace atmospheres requires the development of high-throughput aerosol collectors that are compact, hand-portable, and can be operated using personal pumps. We describe the design and characterization of a compact, high flow, Turbulent-mixing Condensation Aerosol-in-Liquid Concentrator (TCALC) that allows direct collection of aerosols as liquid suspensions, for off-line chemical, biological, or microscopy analysis. The TCALC unit, measuring approximately 12 × 16 × 18 cm, operates at an aerosol sample flowrate of up to 10 L min-1, using rapid mixing of a hot flow saturated with water vapor and a cold aerosol sample flow, thereby promoting condensational growth of aerosol particles. We investigated the effect of operating parameters such as vapor temperature, growth tube wall temperature, and aerosol sample flowrate, along with the effect of particle diameter, inlet humidity, aerosol concentration, and operation time on TCALC performance. Nanoparticles with an initial aerodynamic diameter ≥ 25 nm could grow to droplet diameters > 1400 nm with an efficiency ≥ 80%. Good droplet growth efficiency was achieved for sampled aerosol relative humidity ≥ 9%. We measured complete aerosol collection for concentrations of ≤ 3×105 cm-3. The results showed good agreement between the particulate mass collected through the liquid collector and direct filter collection. The TCALC eliminates the need for sample preparation and filter digestion during chemical analysis, thereby increasing sample recovery and substantially improving the limit of detection and sensitivity of off-line trace analysis of collected liquid samples.
Towards understanding the first genome sequence of a crenarchaeon by genome annotation using clusters of orthologous groups of proteins (COGs)

Background:
          Standard archival sequence databases have not been designed as tools for genome annotation and are far from being optimal for this purpose. We used the database of Clusters of Orthologous Groups of proteins (COGs) to reannotate the genomes of two archaea, Aeropyrum pernix, the first member of the Crenarchaea to be sequenced, and Pyrococcus abyssi.
        
        
          Results:
          A. pernix and P. abyssi proteins were assigned to COGs using the COGNITOR program; the results were verified on a case-by-case basis and augmented by additional database searches using the PSI-BLAST and TBLASTN programs. Functions were predicted for over 300 proteins from A. pernix, which could not be assigned a function using conventional methods with a conservative sequence similarity threshold, an approximately 50% increase compared to the original annotation. A. pernix shares most of the conserved core of proteins that were previously identified in the Euryarchaeota. Cluster analysis or distance matrix tree construction based on the co-occurrence of genomes in COGs showed that A. pernix forms a distinct group within the archaea, although grouping with the two species of Pyrococci, indicative of similar repertoires of conserved genes, was observed. No indication of a specific relationship between Crenarchaeota and eukaryotes was obtained in these analyses. Several proteins that are conserved in Euryarchaeota and most bacteria are unexpectedly missing in A. pernix, including the entire set of de novo purine biosynthesis enzymes, the GTPase FtsZ (a key component of the bacterial and euryarchaeal cell-division machinery), and the tRNA-specific pseudouridine synthase, previously considered universal. A. pernix is represented in 48 COGs that do not contain any euryarchaeal members. Many of these proteins are TCA cycle and electron transport chain enzymes, reflecting the aerobic lifestyle of A. pernix.
        
        
          Conclusions:
          Special-purpose databases organized on the basis of phylogenetic analysis and carefully curated with respect to known and predicted protein functions provide for a significant improvement in genome annotation. A differential genome display approach helps in a systematic investigation of common and distinct features of gene repertoires and in some cases reveals unexpected connections that may be indicative of functional similarities between phylogenetically distant organisms and of lateral gene exchange.
Patent AT-E399673-T1: [Translated] DRIVER INFORMATION SYSTEM

The system has a control device (2) with functional units to select main functions. Control units select functions of the main functions, a selection unit selects sub functions of the main functions, and a return unit reverts to a start level. A display unit (3) displays vehicle-specific information e.g. speed and number of revolutions and/or control unit related information at various display modes.
CMS Program Statistics - Medicare Hospice

The CMS Program Statistics - Medicare Hospice tables provide use and payment data for hospice. 

For additional information on enrollment, providers, and Medicare use and payment, visit the CMS Program Statistics page.

 

Below is the list of tables:


	MDCR HOSPICE 1.  Medicare Hospices:  Utilization and Program Payments for Medicare Beneficiaries, by Type of Entitlement, Yearly Trend
	MDCR HOSPICE 2.  Medicare Hospices:  Utilization and Program Payments for Medicare Beneficiaries, by Demographic Characteristics and Medicare-Medicaid Enrollment Status
	MDCR HOSPICE 3.  Medicare Hospices:  Utilization and Program Payments for Medicare Beneficiaries, by Area of Residence
	MDCR HOSPICE 4.  Medicare Hospices:  Utilization and Program Payments for Medicare Beneficiaries, by Type of Control and Type of Service Visit
	MDCR HOSPICE 5.  Medicare Hospices:  Utilization and Program Payments for Medicare Beneficiaries, by Level of Care and Site of Service
	MDCR HOSPICE 6.  Medicare Hospices:  Utilization and Program Payments for Medicare Beneficiaries, by Number of Service Visits
Maine 2016 Potential Areas for Addressing Service Gaps for Opioid Treatment

The purpose of the medication-assisted treatment (MAT) facility maps is to identify areas on a state-by-state basis that may be potentially underserved by existing treatment facilities. The maps are created with a methodology that seeks to include the highest potential need areas from individual counties so that county-level stakeholders are also informed. The maps are meant to be used as a tool for policy makers to determine potentially underserved areas—not as a definitive representation of these areas.
Compound 525105: 2,3-Dichloropropyl butyrate

Chemical compound data from PubChem database. IUPAC Name: 2,3-dichloropropyl butanoate. Molecular Formula: C7H12Cl2O2. Molecular Weight: 199.07. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Dear Colleague Letter on Best Practices for Adhering to Early and Periodic Screening, Diagnostic, and Treatment Requirements

On November 22, 2024, the Children’s Bureau (CB) within the Administration on Children, Youth, and Families (ACYF) released a Dear Colleague Letter (DCL) pertaining to the recent guidance issued by the Center for Medicaid and CHIP Services (CMS) entitled, Best Practices for Adhering to Early and Periodic Screening, Diagnostic, and Treatment (EPSDT) Requirements
  
  

 (PDF).

The DCL emphasizes the importance of the new CMS guidance, specifically for child welfare leaders seeking to address health care needs, both as a strategy for preventing entry into the child welfare system, as well as for addressing the needs of children and youth in foster care. The DCL also provides suggested actions for child welfare leaders to serve as valuable thought partners to their Medicaid counterparts in thinking through the benefits of specific Medicaid services across systems.

Metadata-only record linking to the original dataset. Open original dataset below.
Compound 525154: Glycerol-hexapropylene glycol ether, triacetate

Chemical compound data from PubChem database. IUPAC Name: 2-[2-[2-[2-[2-[2-(2,3-diacetyloxypropoxy)propoxy]propoxy]propoxy]propoxy]propoxy]propyl acetate. Molecular Formula: C27H50O12. Molecular Weight: 566.7. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
2024 National Directory of Mental Health Treatment Facilities

TheNational Directory of Mental Health Treatment Facilities - 2024is a listing of federal, state, and local government facilities and private facilities that provide mental health treatment services. It includes treatment facilities that responded to the 2023 National Substance Use and Mental Health Services Survey (N-SUMHSS). The information about each facility that appears in this Directory was provided by that facility in response to the 2023 N-SUMHSS. The N-SUMHSS is conducted annually by the Substance Abuse and Mental Health Services Administration (SAMHSA). The 2024 Directory is available in PDF and Excel formats.The Directory is ordered alphabetically by state, by city within each state, and by facility name within each city. Each facility listing includes codes that represent the services offered and other features of the facility, including codes that indicate services for hearing impaired and non-English-speaking clients. Codes are defined in a key shown on pages v-x of the PDF file and as a separate tab on the Excel version. Please note services offered by a particular facility may change over time. It is suggested to verify the information in this Directory when contacting a facility.
Illinois: 2011-2012 NSDUH

This report presents Illinois\'s estimates for 25 measures of substance use and mental health based on the combined 2011 and 2012 National Surveys on Drug Use and Health (NSDUHs). Topics covered include past month substance use (e.g., illicit drugs, marijuana, cocaine, pain relievers, alcohol, tobacco), substance dependence, abuse, and treatment need, past year serious mental illness (SMI), any mental illness (AMI), suicidal thoughts, and major depressive episode (MDE). Resuts are provided by State and for five age groups: 12 to 17, 18 to 25, 26 or older, 18 or older and all persons 12 or older.
Patent AT-E40110-T1: [Translated] CLEANING AGENTS CONTAINING POLYETHER CARBON ACID DERIVATIVES, THEIR PRODUCTION AND USE.

The invention relates to a process for the preparation of a detergent containing one or more compounds having the formula RCONH(C₂H₄O)<sub>n</sub>CH₂COOH and/or salts thereof, where R represents a linear or branched aliphatic hydrocarbon group with 5-21 carbon atoms and n is a number from 1-20, by amidating, ethoxylating and carboxy­methylating one or more fatty acids having the formula RCOOH and, if so desired, converting all or part of the ether carboxylic acid obtained to a salt thereof, characterised in that an oil or fat is started from and that this oil or fat is aminolysed in the presence of an alkali(ne earth) metal and the reaction mixture obtained is in the usual manner ethoxylayed, carboxymethylated and, if desired, converted in whole or in part to a salt.
Title IV-E Adoption Assistance

The Adoption Assistance Program provides funds to states and participating territories and tribes to facilitate the timely placement of children, whose special needs or circumstances would otherwise make them difficult to place with adoptive families. The program is annually appropriated and funding is awarded as an open-ended entitlement grant. Funding is contingent upon an approved title IV-E plan to administer or supervise the administration of the program.  The program operates in 50 states, the District of Columbia, Puerto Rico, the U.S. Virgin Islands, and federally recognized Tribes with approved title IV-E plans.

Matching funds are provided based on the expenditures made on behalf of children determined eligible for the program.  Funds are available for a one-time payment to assist with the costs of adopting a child as well as for monthly subsidies to adoptive families who enter into an adoption assistance agreement to assist with the care of the eligible child.  The program provides federal matching funds at the Federal Medical Assistance Percentage, ranging from 50 to 83 percent, for adoption assistance payments, depending on the per capita income of the state or Tribe. Additionally, funds are available for: administrative costs to manage the program; training staff and adoptive parents; adoptive parent recruitment; and other related expenses. Allowable administrative activities are matched at 50 percent and allowable training costs at 75 percent.  The Title IV-E agency must submit quarterly reports of estimated and actual program expenditures and the average monthly number of children served.

FY 2024: $4.7 billion

Metadata-only record linking to the original dataset. Open original dataset below.
Patent AT-E399886-T1: [Translated] COMPOSITION FOR THE PRODUCTION OF METAL COMPOSITES

In one embodiment, a composition (10) to be mixed with a molten metal to make a metal matrix composite, the composition characterized by: a ceramic reinforcing filler (12), the ceramic reinforcing filler not being wettable by molten aluminum and/or not being chemically stable in molten aluminum, the ceramic reinforcing filler being coated with a ceramic material, the ceramic material being wettable by and chemically stable in molten aluminum. In a related embodiment, a composition (20) to make a porous preform to be infiltrated by molten metal to make a metal matrix composite, the composition characterized by: a ceramic reinforcing filler (23), the ceramic reinforcing filler not being wettable by molten aluminum, the ceramic reinforcing filler being coated with a ceramic material (22) and optionally with a metal (21) such as nickel, the ceramic material being wettable by molten aluminum. The ceramic material can be coated on the ceramic reinforcing filler by a vacuum deposition technique such as vacuum sputtering.
Compound 530536: 4-Butylbenzoic acid, tridecyl ester

Chemical compound data from PubChem database. IUPAC Name: tridecyl 4-butylbenzoate. Molecular Formula: C24H40O2. Molecular Weight: 360.6. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
NNDSS - TABLE 1W. Meningococcal disease, All serogroups to Meningococcal disease, Serogroup B

NNDSS - TABLE 1W. Meningococcal disease, All serogroups to Meningococcal disease, Serogroup B - 2021. In this Table, provisional cases* of notifiable diseases are displayed for United States, U.S. territories, and Non-U.S. residents.

Notice: Due to data processing issues at CDC, data for the following jurisdictions may be incomplete for week 7: Alaska, Arizona, California, Connecticut, Delaware, Florida, Hawaii, Louisiana, Maryland, Michigan, Missouri, North Dakota, New Hampshire, New York City, Oregon, Pennsylvania, and Rhode Island.

Note: 
This table contains provisional cases of national notifiable diseases from the National Notifiable Diseases Surveillance System (NNDSS). NNDSS data from the 50 states, New York City, the District of Columbia and the U.S. territories are collated and published weekly on the NNDSS Data and Statistics web page (https://wwwn.cdc.gov/nndss/data-and-statistics.html). Cases reported by state health departments to CDC for weekly publication are provisional because of the time needed to complete case follow-up. Therefore, numbers presented in later weeks may reflect changes made to these counts as additional information becomes available. The national surveillance case definitions used to define a case are available on the NNDSS web site at https://wwwn.cdc.gov/nndss/. Information about the weekly provisional data and guides to interpreting data are available at: https://wwwn.cdc.gov/nndss/infectious-tables.html. 

Footnotes:
U: Unavailable — The reporting jurisdiction was unable to send the data to CDC or CDC was unable to process the data.
-: No reported cases — The reporting jurisdiction did not submit any cases to CDC.
N: Not reportable — The disease or condition was not reportable by law, statute, or regulation in the reporting jurisdiction.
NN: Not nationally notifiable — This condition was not designated as being nationally notifiable.
NP: Nationally notifiable but not published.
NC: Not calculated — There is insufficient data available to support the calculation of this statistic.
Cum: Cumulative year-to-date counts.
 Max: Maximum — Maximum case count during the previous 52 weeks.
  * Case counts for reporting years 2020 and 2021 are provisional and subject to change. Cases are assigned to the reporting jurisdiction submitting the case to NNDSS, if the case's country of usual residence is the U.S., a U.S. territory, unknown, or null (i.e. country not reported); otherwise, the case is assigned to the 'Non-U.S. Residents' category. Country of usual residence is currently not reported by all jurisdictions or for all conditions. For further information on interpretation of these data, see https://wwwn.cdc.gov/nndss/document/Users_guide_WONDER_tables_cleared_final.pdf. 
†Previous 52 week maximum and cumulative YTD are determined from periods of time when the condition was reportable in the jurisdiction (i.e., may be less than 52 weeks of data or incomplete YTD data).
2020 Uniform Reporting System (URS) Table For Federated States Of Micronesia

This is the 2020 Uniform Reporting System (URS) Output Tables for Federated States Of Micronesia. The URS state reporting system is collected annually to support the Community Mental Health Services Block Grant program. State Mental Health Authorities report on National Outcome Measures (NOMS), evidence based practices, and utilization measures providing an overview of state mental health delivery systems.